The London-based company aims to help combat late-stage cancers using proprietary technology
Around 300 women in England with HER2-negative early breast cancer will be eligible for the new drug each year
The drug could extend patients’ lives by as much as eight months, data suggests
By Cindy Moy Carr and Tami Wahl
Protai aims to increase accuracy in drug discovery and improve the development process
The breast cancer screening pod has been installed at Queen Elizabeth Hospital in Gateshead
2020 saw an estimated 8.8 million cancer cases in women globally
The boards of directors of both companies have unanimously approved the transaction
The femtech industry is not only focused on product development but also on addressing the gender gap in healthcare
Exposing IVF errors could be key to improving the standard of care, embryologists have said, after a California couple sued their fertility clinic over an embryo...
